EarningsExpected EPS accretion of 35% is very solid, and it is believed to be achievable.
Growth StrategyThe company is expected to be on the hunt for growth, both organically and through deals, highlighted by the ESSA deal which is anticipated to increase total assets to $8.5 billion.
ValuationThe shares are considered undervalued at approximately 85% of P/TBV, indicating a compelling value at current levels despite a strong ROA/ROTCE outlook and solid credit quality history.